The researchers established the suitability of FraC nanopores for protein analysis and offered a new approach to driving proteins into nanopores for detection.
The company is working on a variety of updates for existing platforms, including a disposable MinIon flow cell for diagnostic applications, as well as on new nanopore devices.
In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.
During a live webcast today, CTO Clive Brown provided updates on several products and processes, including the PromethIon, base calling, and 1D2 reads.
